Evidence map›Paper›PMID 26293609›Full record

ArticleBMC microbiology2015

Antibacterial and anti-biofilm activity of mouthrinses containing cetylpyridinium chloride and sodium fluoride.

Joe Latimer, Jodie L Munday, Kara M Buzza, Sarah Forbes, Prem K Sreenivasan, Andrew J McBain

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 64 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Antimicrobial cetylpyridinium chloride causes functional inhibition of mitochondria as potently as canonical mitotoxicants, nanostructural disruption of mitochondria, and mitochondrial CaFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2024
    Article
  7. Article
  8. Evaluation of the antibacterial activity of Enamelast® and Fluor defender® fluoride varnishes against Streptococcus mutans biofilm: an in vitro study in primary teeth.European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. High Counts and Anthracene Degradation Ability ofFrontiers in microbiology · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. Hydroxyapatite in Oral Biofilm Management.European journal of dentistry · 2019
    Article
  18. Article
  19. Inhibition ofBiotechnology reports (Amsterdam, Netherlands) · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Joe LatimerManchester Pharmacy School, The University of Manchester, Oxford Road, Manchester, M13 9PT, UK. joe.latimer@manchester.ac.uk.
Jodie L MundayManchester Pharmacy School, The University of Manchester, Oxford Road, Manchester, M13 9PT, UK. jodie.munday@manchester.ac.uk.
Kara M BuzzaManchester Pharmacy School, The University of Manchester, Oxford Road, Manchester, M13 9PT, UK. kara.buzza@manchester.ac.uk.
Sarah ForbesManchester Pharmacy School, The University of Manchester, Oxford Road, Manchester, M13 9PT, UK. sarah.forbes@manchester.ac.uk.
Prem K SreenivasanColgate-Palmolive Technology Center, Piscataway, NJ, USA. prem_sreenivasan@colpal.com.
Andrew J McBainManchester Pharmacy School, The University of Manchester, Oxford Road, Manchester, M13 9PT, UK. andrew.mcbain@manchester.ac.uk.
Colgate-Palmolive (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCetylpyridinium chloride (CPC) and sodium fluoride augment oral hygiene by inactivating bacteria and inhibiting enamel demineralisation, respectively. However, there are few reports in the literature documenting the antibacterial efficacy of their combined use in mouthrinses. We have used six experimental systems to compare the antibacterial effects of mouthrinses containing 0.075% CPC (test rinse, TR) or 0.075% CPC with sodium fluoride (test fluoride rinse, TFR).

resultsEffects against planktonic bacteria were determined using viable counting (for Streptococcus mutans and salivary bacteria), a redox dye (for Actinomyces viscosus and salivary bacteria) and viable counting (for ex vivo oral rinses). Effects against saliva-derived biofilms were quantified using confocal microscopy and differential viable counting. Inhibition of biofilm formation was evaluated by pre-treating hydroxyapatite coupons with mouthrinses prior to inoculation. Otherwise-identical controls without CPC (control rinse and control fluoride rinse, CR and CFR, respectively), were included throughout. Compared to the controls, TFR and TR demonstrated significant antimicrobial effects in the redox assays, by viable counts (>3 log reductions) and in oral rinse samples (>1.25 log reductions, p < 0.05). TFR and TR also significantly reduced the viability of oral biofilms. Pre-treatment of hydroxyapatite with TFR and TR significantly inhibited biofilm formation (>3 log difference, p < 0.05). Overall, there were no consistent differences in the activities of TR and TFR.

conclusionsSodium fluoride did not influence the antibacterial and anti-biofilm potency of CPC-containing formulations, supporting the combined use of CPC and sodium fluoride in mouthrinses to control oral bacteria and protect tooth enamel.

Indexed as

AdultAnti-Infective Agents, LocalBiofilmsCetylpyridiniumFemaleHumansMaleMicrobial ViabilityMouthwashesSodium FluorideTreatment OutcomeYoung AdultAnti-Infective Agents, LocalCetylpyridiniumMouthwashesSodium Fluoride

Identifiers

PMID26293609
PMCPMC4546200
OpenAlexW1911651914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.